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Replicative cycleArboviruses (or arthropod-borne viruses), represent a threat for the new century. The 2005–2006 year
unprecedented epidemics of chikungunya virus (CHIKV) in the French Reunion Island in the Indian Ocean,
followed by several outbreaks in other parts of the world such as India, have attracted the attention of
clinicians, scientists, and state authorities about the risks linked to this re-emerging mosquito-borne virus.
CHIKV, which belongs to the Alphaviruses genus, was not previously regarded as a highly pathogenic
arbovirus. However, this opinion was challenged by the death of several CHIKV-infected persons in
Reunion Island. The epidemic episode began in December 2005 and four months later the seroprevalence
survey report indicated that 236,000 persons, more than 30% of Reunion Island population, had been
infected with CHIKV, among which 0.4–0.5% of cases were fatal. Since the epidemic peak, the infection case
number has continued to increase to almost 40% of the population, with a total of more than 250 fatalities.
Although information available on CHIKV is growing quite rapidly, we are still far from understanding the
strategies required for the ecologic success of this virus, virus replication, its interactions with its
vertebrate hosts and arthropod vectors, and its genetic evolution. In this paper, we summarize the current
knowledge of CHIKV genomic organization, cell tropism, and the virus replication cycle, and evaluate the
possibility to predict its future evolution. Such understanding may be applied in order to anticipate future
epidemics and reduce the incidence by development and application of, for example, vaccination and
antiviral therapy.
© 2009 Elsevier Inc. All rights reserved.Introduction
Most of the emerging viral infections in humans, originate from
known zoonosis. Pathogens have been engaged in long-standing and
highly successful interactions with their hosts since their origins.
Strategies have evolved that maximize invasion rate, ensuring timely
replication and survival both within-host and between-host, thus
facilitating reliable transmission to new susceptible hosts. It is
therefore extremely important to better understand the evolutionary
events that shape the genotype–phenotype of pathogens and
reciprocally to determine how cells from human and non-human
species resist to infection so that ultimately novel molecules may be
designed to protect permissive cells from viral infection.Western equine encephalitis;
uine encephalitis; SF, Semliki
mu; ONN, O'nyong-nyong; RR,
; C-ter, C-terminal; N-ter, N-
athogènes et Biotechnologies
, CS69033, 34965 Montpellier
. Devaux).
ll rights reserved.Viruses are exquisitely adapted to host parasitization and have
selected host traits that reduce their impact on host life span and
fecundity. Lessons from molecular clocks tell us that viruses already
populated our planet a few billion years ago (Doolittle et al., 1996)
whereas our ﬁrst ancestor, Sahelanthropus tachadensis, lived in Africa
about 7 million years ago and Homo sapiens emerged about
150,000 years ago, subsequently spreading throughout the world
(Tishkoff et al., 2000). Consequently, since humans ﬁrst evolved they
have been exposed to viruses. Gathering information related to the
ecological variations and the dynamics of viral–host co-evolution, is
critical to better understand the underlying mechanisms of viral
emergence or re-emergence that is responsible for serious diseases
in human populations. Viral infectious diseases in humans constitute
one of the main challenges that medical science must meet in the
coming century. The vast majority of emerging and re-emerging
viral infectious diseases responsible for devastating human illnesses,
such as AIDS, hepatitis or hemorrhagic fevers, are caused by viruses
with RNA genomes. Among these RNA viruses, arthropod-borne
(arbo-)viruses, are especially important since many cause fatal
diseases in humans and domestic animals. The Alphaviruses genus,
that includes the group of viruses to which chikungunya virus
(CHIKV) belongs, originated around 2000 to 3000 years ago (Weaver
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mosquitoes, was originally isolated in 1952 from the serum of a
febrile patient from the Makonde Plateau in Tanzania (Robinson,
1955; Ross, 1956). The CHIKV-associated symptoms observed 2–
7 days following infection are characterized by chills and fever
between 39 °C and 40 °C, headache (almost 70% of the patients),
nausea/vomiting (about 60% of the patients), persistent myalgia/
arthralgia (about 40% of patients; the poly-arthralgia is frequently
very painful), and maculopapular rash (almost 60% of the patients).
These symptoms are often clinically indistinguishable from those
caused by dengue virus (DENV) which affects nearly 80 million
people a year. Such similarity in clinical symptoms probably
accounts for frequent misclassiﬁcation and some underreporting of
CHIKV infection in areas with endemic DENV (Carey, 1971).
However, dual infections may occur in some cases (Myers and
Carey, 1967). CHIKV-associated symptoms were also found to be
very similar to those previously observed in Australia during unusual
epidemic episodes caused by a related virus, the Ross River virus
(RRV) (Nimmo, 1928; Weber, Oppel, and Raymon, 1946). CHIKV has
also been isolated from Australian patients (Harnett and Bucens,
1990).
Since 2005 it has become clear that CHIKV infection of humans can
also cause fatal disease in a small percentage of infected patients.
Since the ﬁrst identiﬁcation of CHIKV-infected humans in 1952,
outbreaks of CHIKV have occurred throughout African and Asian
countries where it was responsible for illnesses in hundreds to
thousands of individuals. Comparative observations of Asian and
African episode of CHIKV have been reported (Nakao, 1972). In both
Africa and Asia, the re-emergence was unpredictable, with intervals of
7 years to 20 years between consecutive epidemics. For example,
cases of chikungunya in Indonesia were reported between 1973 and
1983. After a hiatus of 20 years, 24 distinct CHIKV outbreaks were
reported during 2001 to 2003 (Berger, 2005).
The factors determining the risk for chikungunya epidemics are
poorly understood. These factors are likely similar to those that
determine the risk for RRV, and therefore RRV is a very informative
model for Alphavirus-induced epidemics (Harley, Sleigh, and Ritchie,
2001). Epidemic determinants include adequate populations of
reservoir hosts (potentially humans in some settings), vector
mosquitoes, and appropriate climatic conditions for transmission.
CHIKV is known for its wide geographic distribution (Strauss and
Strauss, 1994). The CHIKV epidemic episode which developed in
2004 in the Indian Ocean, resulted in a crisis similar to that
associated with the 1991 RRV epidemic outbreak in Australia
(Harley, Sleigh, and Ritchie, 2001). This explosive outbreak of this
little-known virus possibly makes this the ﬁrst announcement that
major viral threats exist in this region of Indian Ocean. This part of
the world meets a number of criteria (ecological, geopolitical,
climatical, social …), that are conducive to the emergence of other
viral epidemic episodes. Re-emergence of CHIKV was also recorded
in India during 2005–2006 (Arankalle et al., 2007). To understand
what occurred in Reunion Island, it is important to better know the
genetic nature of the virus, the ecology of vectors and reservoirs. We
have recently reviewed the ecological and evolutionary perspective
of CHIKV threat (Chevillon et al., 2008). A major challenge also
concerns the characterization of the virus replication cycle. Efforts in
virology basic research are required to better deﬁne the molecular
interactions between the CHIKV and cells from different tissue
origins. Such information is needed for understanding the patho-
physiology of CHIKV-associated disease and developing drugs for
future CHIKV therapy. The main objective of this review is to
summarize the knowledge accumulated on the CHIKV replicative
cycle and to discuss possible mechanisms of molecular crosstalk
between the virus and host cell with respect to our most recent data
and other data from the CHIKV literature, and also by extrapolating
from publications related to other Alphaviruses.CHIKV, a member of arboviruses
In the early 1940s, workers at the Rockefeller Foundation
demonstrated that arboviruses could be discriminated by serological
tests. Using hemagglutination inhibition and neutralization assays, it
was suggested that Western equine encephalitis virus (WEEV),
Eastern equine encephalitis virus (EEEV), Venezuelan equine enceph-
alitis virus (VEEV) and Semliki Forest virus (SFV) are related but
distinct. They were clustered in a group called A, whereas a second
interrelated group B included dengue virus (DENV), Japanese
encephalitis virus (JEV), Ntaya virus (NTAV), West Nile virus
(WNV), and yellow fever virus (YFV) (Casals and Brown, 1954).
Subsequently, electron microscopy, biochemical and genetic charac-
terization of these viruses led to placement of both group A and group
B arboviruses in a single virus family named Togaviridae. More
recently, the classiﬁcation was revisited based upon gene sequences,
replication strategies, and structure of these viruses which resulted in
the ﬁnal assignment of the different arbovirus groups into Flavivirus
or Alphavirus genus (Westaway et al., 1985). The Flavivirus genus
includes more than 70 single-stranded RNA viruses divided into
8 serogroups (Chambers et al., 1990). The Alphavirus genus consists of
29 species of arboviruses that have been classiﬁed into 7 antigenic
complexes: Barmah Forest (BF), Eastern equine encephalitis (EEE),
Middelburg (MID), Ndumu (NDU), Semliki Forest (SF), Venezuelan
equine encephalitis (VEE), and Western equine encephalitis (WEE).
Alphaviruses have a wide geographic distribution (Strauss and Strauss,
1994). CHIKV is part of the SF group of Old World Alphaviruses that
includes SFV, ONNV, and RRV. Most of the Old World Alphaviruses
cause fever, rash and arthralgia while many of the New World Al-
phaviruses cause encephalitis. The seven antigenic complexes are
indeed reﬂecting clades of viruses that share medically important
characteristics.
The availability of partial or complete sequence data (Charrel,
Zandotti, and de Lamballerie, 2006; George and Raju, 2000; Khan et
al., 2002; Powers et al., 2001; Powers et al., 2000; Schuffenecker et al.,
2006; Yadav et al., 2003) unsurprisingly indicated that genetic
relationships are in agreement with the antigenically-based classiﬁ-
cation. Evolutionary relationships of Alphaviruses present some
intriguing questions regarding the origin of the genus and subsequent
species distribution and geographical expansion. For example, most of
the NewWorld viruses in theWEE antigenic group (WEEV, Highlands
J virus, Fort Morgan virus) have emerged from an ancestral virus that
results from a recombination between the E2 and E1 gene from a
Sindbis-like virus and the remaining genome from an EEEV-like
ancestor (Hahn et al., 1988; Weaver et al., 1997). On the basis of
evolutionary rate estimation, it was calculated that this recombination
may have occurred in the NewWorld roughly 1300 to 1900 years ago,
after the divergence of Aura virus from the ancestor of the Sindbis-
related viruses (Weaver et al., 1997). Regarding dissemination, it has
been proposed that Alphaviruses originated in the New World and
were spread to the Old World twice, once to generate the SIN group,
and once to create the SF group (Levinson, Strauss, and Strauss, 1990).
Alternatively it has been suggested that the Alphaviruses originated
either in the NewWorld or the OldWorld and thenwere spread to the
other hemisphere about 2000 to 3000 years ago (Weaver et al., 1993).
Among New World Alphaviruses, analysis of the South American
group of EEEV suggested that Peru–Brazil EEEV have diverged from
Argentina–Panama EEEV roughly 450 years ago (Weaver et al., 1994).
Another surprising observation concerns the Middleburg virus
(MIDV); MIDV which forms an independent cluster according to
several phylogenetic analyses, falls into the group of CHIKV and SF-
related viruses when phylogenetic trees are built from partial E1
nucleotide sequence (Powers et al., 2001) (Fig. 1). Evolutionary
studies have also been reported for the SF group in Old World Al-
phaviruses that revealed some interesting genetic features relevant to
evolution; an ancestor of the SFV, RRV, ONNV, and CHIKV groups
Fig. 1. A simpliﬁed phylogenetic tree of Alphaviruses assuming their New World origin, adapted from Powers et al. (2001). This ﬁgure illustrates the evolution of Alphaviruses
generated from partial E1 envelope glycoprotein sequence and highlights the evolution of CHIKV. Only 6 of the 7 antigenic complexes are shown because MIDV, which forms an
antigenic complex independent from the other using several phylogenetic analyses, fall into the group of CHIKV and other virus from the SF group when phylogenetic tree is
deducted from partial E1 nucleotide sequence. Readers are invited to refer to the excellent paper by Powers et al. (2001) for more details. It is worth noting that WEEV arose by
recombination between EEEV and the Sindbis virus (Hahn et al., 1988; Weaver et al., 1997). The recombinant virus contains the glycoprotein of the SINV-like parent but the
nucleocapsid protein of the EEEV parent.
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World with complicity of the migratory animal reservoir, likely birds
(Weaver et al., 1997), and next is expected to have spread in the Old
World. It has been postulated that CHIKV evolved in Africa where it is
maintained in a sylvatic cycle involving wild primates and Aedes spp.
mosquitoes, and was subsequently introduced into Asia, where it was
typically associated with Aedes aegypti mosquitoes (Powers et al.,
2000). This virus is currently transmitted by Aedes albopictus in urban
areas (Kumar et al., 2008).
Sequence comparisons in E1 indicated, for example, that the TA53
CHIKV isolate, collected from Tanzania in 1953, showed 98.5% and
97.5% nucleotide identity with the SA76 South African isolate
collected in 1976 and the Ugandan UG82 strain isolated in 1982,
respectively. A high identity (97.7%) was also observed between TA53
and the recent Reunion Island isolate OPY-1. In contrast TA53 and
OPY-1 showed only 85.2% and 84.8% nucleotide identity in E1with the
37997 West African strain. Using evolutionary rate estimation based
on E1 nucleotide sequence comparison of CHIKV with different
origins, it was predicted (Powers et al., 2000), that the Asian CHIKV
genotype evolved from a hypothetical African ancestor approximately
50 to 430 years ago. Interestingly, the closely related virus ONNV is
believed to have evolved from a CHIKV-like virus that adapted to
Anopheles mosquito vector (Johnson, 1988), typically A. funestus and
A. gambiae. Yet, other authors who performed phylogenetic E1
nucleotide sequence analysis hypothesized that CHIKV and ONNV
are genetically distinct (Lanciotti et al., 1998; Powers et al., 2000). It is
noteworthy that CHIKV, like RRV and BFV, uses the culicine
mosquitoes Aedes, as their vector. An interesting biological difference
has been recorded between CHIKV and ONNV, since CHIKV replicates
in an A. aegypti cell line whereas ONNV does not (Chanas et al., 1979;
Vanlandingham et al., 2005a). In addition, CHIKV also replicates in an
A. albopictus C6/36 cell line (Igarashi, 1978; Pyke et al., 2004), which is
also known to support RRV replication. Experiments with infectious
clones of CHIKV and ONNV to produce chimeric viruses, demonstrated
that infection of A. gambiae requires the entire ONNV structural gene
sequences (Vanlandingham et al., 2005a; Vanlandingham et al.,
2005b). It was postulated that the conserved repeated sequence
elements in the 3′-non-translatable region of Alphavirusesmay have a
function in vector speciﬁcity (Khan et al., 2002). During the recent
outbreak of CHIKV in the Indian Ocean territories, CHIKV samples
were isolated from 127 patients from Reunion, Seychelles, Mauritus,
Madagascar, and Mayotte islands and both complete nucleotide
sequence of six selected isolates and partial E1 nucleotide sequence
were used to build phylogenetic tree (Schuffenecker et al., 2006). Thisstudy demonstrated that the outbreakwas initiated by a strain related
to an East-African isolate. Sequence comparison between viruses
isolated from Reunion Island and from the recent outbreak in the
Kerala region in India indicated that the Indian isolate IND-06 shared
99.9% nucleotide identity with the reference Reunion Island isolates.
Three unique substitutions were noted in the IND-06 isolate: two
(T128K and T376M) in the nsP1 region and one (P23S) in the capsid
protein (Arankalle et al., 2007). Accordingly, these two outbreaks can
be attributed to the circulation of the same strain of CHIV.
CHIKV genomic organization
As a member of the Alphavirus genus, CHIKV is a small (about 60–
70 nm-diameter), spherical, enveloped, positive-strand RNA virus
(Higashi et al., 1967; Powers et al., 2001; Simizu et al., 1984; Strauss
and Strauss, 1994). Alphaviruses are among the simplest membrane-
enveloped viruses. Until recently, only two complete nucleotide
sequences of CHIKV isolated from humans infected during the 1952
Tanzania outbreak were available corresponding to the strain Ross
and the S27 CHIKV African prototype, respectively (Khan et al., 2002).
Another complete nucleotide sequence was established from a CHIKV
strain isolated in A. furcifer mosquito during the 1983 Senegal
outbreak (accession no. AY726732). Additionally, several partial
sequences (e.g., NCBI accession nos. L37661, AF490259, AF023283,
AF192895, AF192907, U94597 (Powers et al., 2000; Yadav et al.,
2003)), were also available fromGenBank, including the 26S sequence
of an Indian Strain M-713424 isolated in Madras (Yadav et al., 2003).
The 2005–2006' Reunion outbreak of CHIKV was such a challenge for
scientists that knowledge about new CHIKV isolates genomic
sequences rapidly increased. Early 2006, the complete sequence of a
CHIKV isolate from Reunion Island was made available through NCBI/
GenBank accession no. DQ443544.1 (Charrel, Zandotti, and de
Lamballerie, 2006). Next, complete sequences of six selected CHIKV
isolates from Reunion and Seychelles islands were reported (Schuffe-
necker et al., 2006). Additionally, this last study also reported partial
sequences of 119 CHIKV isolates from Reunion, Seychelles, Mauritius,
Madagascar and Mayotte islands.
The genome of CHIKV is organized as follows: 5′ cap-nsP1-nsP2-
nsP3-nsP4-(junction region)-C-E3-E2-6k-E1-poly(A)-3′ and is 11,805
nucleotides long, excluding the 5′ cap nucleotide, an I-poly(A) tract
and the 3′ poly(A) tail (CHIKV S27 strain) (Fig. 2). The CHIKV genome
resembles eukaryotic mRNAs in that it possesses 5′ cap structures and
3′ poly(A) tail. Although it has not been speciﬁcally investigated for
CHIKV, it was documented with related Alphaviruses that the 5′ end
Fig. 2. Organization of the CHIKV genome and gene products. The CHIKV genome resembles eukaryotic mRNAs in that it possesses 5′ cap structures and 3′ poly(A) tail. The 5′ and 3′
proximal sequences of CHIKV genome carry non-translatable regions (NTR). The junction region (J) is also non-coding. A subgenomic positive-strand mRNA referred to as 26S RNA,
is transcribed from a negative-stranded-RNA intermediate and serves as the mRNA for the synthesis of the viral structural proteins. The different non-structural proteins (nsP1–
nsP4) and structural proteins (C, Capsid; E1, E2, E3, envelope; 6K) are generated after proteolytic cleavage of polyprotein precursors.
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non-translatable regions (NTR) of CHIKV are composed of 76
nucleotides. The size of the 3′-NTR of Alphaviruses demonstrates an
important heterogeneity. The 3′-NTR of CHIKV is composed of 526
nucleotides. By comparing the length of 3′-NTR of 23 Alphaviruses it
becomes apparent that this part of the viral genome varies strongly,
from 77 nt for Pixuna virus up to 609 nt for Bebaru virus (Pfeffer et al.,
1998). Such variations largely depend on the number of repeated
sequences which could account for sequence insertions into a smaller
ancestral 3′-NTR or to deletions that may also have contributed to
shape this region. Indeed, the 3′-NTR proximal sequences of Alpha-
virus genomes are enriched in A/T nucleotide (ranging from 58% forFig. 3. Schematic representation of repeated sequence elements (RSE) and lengths of 3′-NT
pointing arrow indicates the stop codon of the structural E1 glycoprotein gene region. Both t
shading indicate repeats of unique sequence. The open triangles preceding the poly(A) tail in
The organization of the 3′-NTR in CHIKV revealed two copies of an incomplete RSE found i
sequences speciﬁc for CHIKV (slight sequence variations, below 10%, are found among the th
al. (2002)).Babanki virus to 82% for Buggy Creek virus, two viruses that belong to
the WEE group of viruses). Such feature is known to be critical for
recombination and duplication events leading to homologous recom-
binations in positive-stranded viruses (Nagy and Bujarski, 1996;
Pfeffer, Kinney, and Kaaden, 1998). The 3′-NTR of Alphaviruses are
believed to contain several cis-acting conserved motifs, named
conserved repeated sequence elements (RSEs), which regulate viral
RNA synthesis (Ou, Strauss, and Strauss, 1983; Pfeffer, Kinney, and
Kaaden, 1998). CHIKV 3′-NTR contains two copies of an incomplete
RSE showing an identity with an RSE sequence found in ONNV and
contains three RSEs at positions 11,382–11,416, 11,525–11,559, and
11,611–11,646 similar to RSE motives found in RRV and BFV butRs of CHIKV and related viruses (adapted from Pfeffer et al. (1998)). The downward-
he overall lengths of the 3′-NTR and repeats have been drawn to scale. Different types of
dicate the 19-nt that is a highly conserved sequence element (CSE), among Alphaviruses.
n ONNV and three copies of RSE that represent the entire RRV-type RSE and repetitive
ree RSE). The location of I-poly(A) in 3′-NTR of CHIKV is indicated (according to Khan et
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2002; Pfeffer, Kinney, and Kaaden, 1998) (Fig. 3). Nucleotide sequence
alignment revealed a four nucleotide difference and one nucleotide
difference accompanied by one insertion in the second and third RSE
motives, respectively. A deletion of RSEs in model Alphaviruses usually
causes a reduced and delayed viral release in different cell types,
suggesting a possible interaction with generally unknown cellular
proteins involved in virus production, tissue speciﬁcity or both (Kuhn
et al., 1991). For SINV, binding sites for cellular proteins have been
identiﬁed in the 3′-NTR of the viral RNA (Pardigon, Lenches, and
Strauss, 1993), opening new avenues for research. Interestingly, a 19-
nt conserved sequence element directly adjacent to the poly(A) tract
was found in all Alphaviruses, supporting the hypothesis that this
region is a cis-acting sequence element during viral replication which
possibly plays an essential role for virus growth, likely by acting as an
essential initiation site for the viral replicase (Pfeffer, Kinney, and
Kaaden, 1998; Strauss and Strauss, 1994). Yet it has also been claimed
that deletions of the CSE do not prevent Alphaviruses replication
(George and Raju, 2000). Finally, an internal poly(A) tract (I-poly(A))
has been described in the 3′-NTR of a highly passaged strains (Khan et
al., 2002) while it does not exist in other CHIKV genomes (Pfeffer,
Kinney, and Kaaden, 1998). The biological signiﬁcance of this motif is
unclear. Interestingly, three insertion/deletion events, two of which
were observed in the 3′-NTR, were reported when nucleotide
sequences from the S27 CHIKV strain and Reunion Island CHIKV
isolates were compared (Schuffenecker et al., 2006). First the long I-
poly(A) stretch observed in the S27 strain was replaced by a stretch of
only 5 adenine nucleotides in Indian Ocean; second, a GAA codon was
missing. The junction region of CHIKV which is also untranslated is
composed of 68 nucleotides. Using SINV as a model, it has been shown
that this region contains an internal promoter for transcription of the
subgenomic mRNA, and the start site and 5′-non-translated leader
sequence of the 26S mRNA (Grakoui et al., 1989).
The genome of the S27 CHIKV strain, similarly to the other Al-
phaviruses, contains two open reading frame (ORF) of 7424 nt and
3732 nt that encode non-structural and structural proteins of CHIKV,
respectively (Fig. 2). A 1.13% sequence divergence (28 amino acid
changes) was observed in non-structural proteins when compared
with the 05.115 Reunion isolate with the highest diversity observed in
nsP3 (2.26%) and the lowest in nsP2 (0.6%). One important difference
reported by Schuffenecker et al. (2006), was the presence of an opal
stop codon (UGA) in nsP3 instead of a CGA coding for an arginin in
S27, the function of which is likely the regulation of the putative
polymerase nsP4 protein expression by a read-through mechanism
(Strauss et al., 1988). In addition, the capsid and E1 and E2 envelope
glycoproteins showed 0.38%, 0.68% and 3.3% amino acid variation,
respectively. Notably, with 14 amino acid changes, the envelope E2
protein showed the highest sequence variation.
CHIKV entry into human cells
Alphaviruses envelope glycoproteins function is attachment to
cells. Despite the 3-D structure of CHIKV E1 glycoprotein has not been
solved so far by crystallographic methods, the primary sequence is
quite similar to the E1 fusion protein of SFV and it is likely that the 3-D
folding of these related proteins is similar. Interestingly, the E1
protein of SFV revealed a remarkable ﬁt to the available scaffold of
Tick-borne encephalitis virus (TBEV, a ﬂavivirus) (Lescar et al., 2001).
Recently, a model for the CHIKV E1 structure became available
(Schuffenecker et al., 2006). The E1 and E2 glycoproteins are expected
to form heterodimers that associate as trimeric spikes on the viral
surface.
Enveloped viruses utilize membrane-bound receptor(s) for entry
into speciﬁc target host cells (Smith et al., 1995). The vertebrate host
spectrum of arboviruses varies for each virus (Calisher, 1994;
Chevillon et al., 2008; Higashi et al., 1967; Jupp and McIntosk, 1988;Rinaldo et al., 1975; Stim and Henderson, 1969). Within their
mammalian hosts, arboviruses usually replicate in a wide variety of
cells (Eaton and Hapel, 1976; Giovarelli et al., 1977; Heller, 1963;
Murphy et al., 1973; Precious et al., 1974). The identity of some
arbovirus receptors has been reported. The dendritic-cell-speciﬁc
ICAM3-grabbing non-integrin (DC-SIGN or CD209)was found to serve
as a receptor both for SINV (Klimstra et al., 2003) and for DENV (Kwan
et al., 2005; Navarro-Sanchez et al., 2003; Tassaneetrithep et al.,
2003). The laminin receptor and glycosaminoglycans have also been
suggested to play a role for SINV entry (Lee et al., 2002; Wang et al.,
1992). Interestingly, a laminin-like receptor in mosquito cells was
suggested as the target for VEEV envelope glycoprotein (Strauss and
Strauss, 1994). Although this review focuses on CHIKV tropism for
human cells it is impossible to ignore that the virus transmission cycle
requires infection of female mosquitoes via a viremic blood meal and,
following a suitable extrinsic incubation period, transmission to
another vertebrate host during subsequent feeding (Higgs and Beaty,
2004). However, despite able to replicate both in mosquitoes and
higher vertebrate cells, neither mosquito cell surface receptor(s) nor
human cell surface receptor(s) have been identiﬁed to date for CHIKV.
This is an important question to be addressed. Determining to which
cell types CHIKV can attach and productively infect are important
issues required to understand the pathophysiology of CHIKV infection
in humans. The ability of CHIKV to bind human cells and to replicate in
cell cultures was only recently documented. In the absence of
experimental evaluation of target cells, one could expect CHIKV to
bind and infect a broad range of cell lines similarly to those infected by
related Alphaviruses. To support this hypothesis, the related virus RRV
was reported to persistently and productively infect a large variety of
cells including human synovial cells (Cunningham and Fraser, 1985;
Journeaux, Brown, and Aaskov, 1987), ﬁbroblasts (Journeaux, Brown,
and Aaskov, 1987), macrophages (Linn and Suhrbier, 1997; Linn et al.,
1996) and CD4+ lymphocytes found in the mononuclear synovial
effusion of patients with epidemic polyarthritis (Fraser and Becker,
1984). Similarly, VEEV can infect a broad array of human cell types
(Kolokoltsov, Weaver, and Davey, 2005). It has been already
documented that CHIKV can infect the epithelial FL cells that derive
from the human amniotic membrane (Mantani et al., 1967) and
human lung MRC-5 cells which are routinely used for CHIKV
production (Edelman et al., 2000). However, the ﬁrst extensive
study of human cell lines and cellular subpopulations supporting virus
replication in vitro, was published only two years ago (Sourisseau et
al., 2007). This work demonstrated that binding of CHIKV and
infectivity are limited to some cells lines and cellular subpopulations,
indicating that CHIKV, like the other enveloped viruses, demonstrates
a tropism for cells expressing an as yet unidentiﬁed surface receptor
(s) that is not ubiquitously expressed on human cells. We have also
further investigated CHIKV tropism for human cell types (Solignat et
al., submitted for publication), by counting ﬂuorescent cells that
express the green ﬂuorescent protein (GFP) following exposure to the
strain 5′CHIKV-EGFP (Tsetsarkin et al., 2006) and by measuring the
cytopathic effect of the virus in cell culture. We ﬁrst evaluated
whether or not blood-derived cells are sensitive to CHIKV. As
summarized in Table 1, H9, a CD4+ T lymphoid cell line as well as
the monocytoid U937 and TPH-1 cell lines and primary dendritic cells
are resistant to CHIKV infection. In addition, primary peripheral blood
mononuclear cells, including primary CD4+ T lymphocytes, primary
CD14+ monocytes and dendritic cells were also reported to be
refractory to CHIKV binding and infection (Sourisseau et al., 2007).
Surprisingly, primary macrophages were highly sensitive to CHIKV
and showed cytopathic effect following CHIKV infection (Fig. 4A).
These data, together with other data from the literature (Sourisseau et
al., 2007) support that primary macrophages are productively
infected by CHIKV. Considering that the B-420 (EBV-transformed B
cell line) was refractory to CHIKV (Sourisseau et al., 2007), these
results suggest that, to the exception of macrophages and platelets,
Table 1
Summary of experiments aimed at investigating the sensitivity of different human cell
lines to CHIKV.
Name Cell type Viral
replication
Cytopathic effect
10−1 10−2 10−3
THP-1 Monocytoid cell line – nd nd nd
U937 Monocytoid cell line – nd nd nd
Dendritic cells Primary monocyte-derived cells – – – –
Macrophages Primary monocyte-derived cells + + + +
H9 T-Lymphocyte-derived cells –
HUH7 Hepatocarcinoma cell line ++ ++ + –
SH-SY5Y Neuroblastoma cell line ++ ++ ++ –
HeLa Cervical carcinoma epithelial
cell line
++ ++ + –
A549 Alveolar epithelial cell line – nd nd nd
HEK-293T Kidney epithelial cell line ++ ++ ++ –
Viral replication was measured 24 h after exposure to the 5′CHIKV-EGFP virus at
25×TCID50. Cells were then ﬁxed using paraformaldehyde and GFP positive cells were
counted under epiﬂuorescence using a Leica microscope. ++: at least 80% of GFP cells;
+: less than 40% of GFP cells. The cytopathic effect was evaluated by MTT assay 48 h
post infection. Cells were infected with the indicated TCID50 dilution (10−1 refers to
25×TCID50). nd: not determined. All results are representative of 3 independent
experiments. CHIKV used is the West African strain 5′CHIKV-EGFP that encodes a GFP
protein (Vanlandingham et al., 2005b).
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derived cells lack CHIKV cell surface receptor(s). These results differ
with respect to the tropism for lymphocytes reported for related
viruses such as RRV and VEEV. CHIKV was also found to bind and
infect a number of cells derived from other tissues. We have observed
(Table 1) that the cervical carcinoma epithelial cell line HeLa, the
kidney epithelial cell line HEK-293T, the hepatocarcinoma epithelial
cell line HUH7, and the neuroblastoma cell line SH-SY5Y are infected
by CHIKV and show cytopathic effects and syncytia formation after
CHIKV exposure (Fig. 4B). In addition, BEAS-2B, Hs 789.Sk skin cells,
dividing and non-dividing MRC-5 lung cells and endothelial cell lines
(TrHBMEC and hCMEC/D3) were also susceptible to CHIKV (Sour-
isseau et al., 2007). Inmuscular tissues, CHIKV infects and replicates in
skeletal muscle progenitor cells, designed as satellite cells, but not in
muscle ﬁbers (Ozden et al., 2007). More recently, it was reported that
the syncytiotrophoblastic cell line BeWo is refractory to CHIKVFig. 4. Representative experiment of analysis of cells sensitivity to CHIKV. (A) Primary macro
revealed by expression of green ﬂuorescence 24 h after exposure to CHIKV. The upper panel
(B) Comparative analysis of CHIKV cytopathic effect into A549 and SH-SY5Y cell cultures.
CHIKV demonstrated syncytia formation and cell death after 48 h of culture (left, bottom pan
culture of A549 cells exposed to CHIKV.(Couderc et al., 2008). In addition to this observation, we found that
CHIKV is unable to replicate in the A549 alveolar epithelial cell line.
Interestingly, the A549 alveolar epithelial cell line was reported to
efﬁciently bind CHIKV. Given that a quite good correlation was
reported between the efﬁciency of viral binding and sensitivity to
infection (Sourisseau et al., 2007), this may suggest that a co-receptor
is lacking at the surface of A549 cell line or that this particular cell type
is protected by a restriction factor, tissue-speciﬁc, acting post-entry. It
is not knownwhethermechanisms of restriction similar to other well-
documented events of cellular resistance to viruses such as these
generated by the tripartite motif proteins (TRIM/RBCC) and apolipo-
protein B mRNA-editing enzymes (APOBEC) in HIV infected cells
(Nisole et al., 2005; Zheng and Peterlin, 2005), exist for CHIKV, but it
would not be surprising to ﬁnd cells resistant to CHIKV by a restriction
mechanism. This hypothesis is reinforced by the existence of a
restriction mechanisms inhibiting EEEV replication after attachment,
entry and uncoating in myeloid lineage cells (Gardner et al., 2008).
Host–CHIKV interactions and clathrin-dependent endocytosis
Cellular requirements for entry in target cells differ among Al-
phaviruses. Cholesterol represents one of the key constituents of small,
dynamic, sterol- and sphingolipid-enriched domains on the plasma
membrane which are called lipid rafts and which compartmentalize
cellular processes. Functionality of lipid rafts is sensitive to cholesterol
depleting agents as β-methyl cyclodextrin (mCD). We recently
investigated the requirement for membrane cholesterol in CHIKV
entry into mammalian HEK-293T cells. Cholesterol depletion of the
target cell membrane signiﬁcantly reduced (up to 65%) infection of
the cells (Solignat et al., data submitted for publication) suggesting
that cholesterol-enriched domains play an important role during
entry of CHIKV particles in human cells. It is worth noting that New
World Alphaviruses (i.e., VEEV) are apparently quite unsensitive to
membrane cholesterol depletion during entry, whereas Old World
Alphaviruses (i.e., SFV) entry into cells is apparently inﬂuenced by
free membrane cholesterol and sphingolipids (Phalen and Kielian,
1991; Waarts et al., 2002). Such differences for cholesterol depen-
dence were suggested to rely on sequence variations in E1 with
implication of amino acid at position 226 (Lu, Cassese, and Kielian,phages were exposed to 25×TCID50 of 5′CHIKV-EGFP (lower panel). Infected cells were
corresponds to uninfected control primary macrophages. DAPI coloration is also shown.
Cells were examined by phase contrast using a Leica microscope. SH-SY5Y exposed to
el) compared to control culture (left, upper panel). No cytopathic effect is evidenced in
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Recently, it was reported that the outbreak of CHIKV in Indian Ocean
Islands, was initiated by a virus expressing a E1 glycoprotein with an
A-226 amino acid but, as the epidemic progressed CHIKV isolated
from the same geographic region expressed either a A-226 or a V-226
and eventually the new V-226 genotype largely dominated in infected
humans (Schuffenecker et al., 2006). Tested in A. albopictus cells, this
mutation was later found to modify the cholesterol dependence of the
virus and to increase the ﬁtness of CHIKV, causing a signiﬁcant
enhancement in the ability of the virus to disseminate into mosquito
secondary organs and to be transmitted to suckling mice (Tsetsarkin
et al., 2007).
Studies performed with SFV, were the ﬁrst to establish the
receptor-mediated endocytosis entry route (Helenius et al., 1980).
Virus access into cells occurs through clathrin-dependent endocytosis
vesicles (Kolokoltsov, Fleming, and Davey, 2006), and anti-clathrin
antibodies experimentally introduced into the cell inhibited endocy-
tosis of SFV (Doxsey et al., 1987). Clathrin-coated vesicules are then
uncoated and form endosomes. We have recently explored CHIKV
infection route in mammalian cells (M. Solignat, submitted for
publication). We addressed the possible involvement of dynamin, a
protein required for severing the clathrin-coated pit from the plasma
membrane to create an autonomous clathrin-coated vesicle, for
transport from the trans Golgi network, as well as for ligand uptake
through the caveolae. We found that Dynasore, a potent inhibitor of
dynamin GTPase activity signiﬁcantly impairs CHIKV infection of
epithelial HEK-293T cells. To further discriminate between clathrin
and caveolae, we examined the effects of a series of well-character-
ized dominant negative mutants for cellular proteins associated with
clathrin-mediated endocytosis or with the caveolar/raft pathway, on
CHIKV infection. We found that a DN mutant of the Eps15 protein,
known to impede the assembly of clathrin-coated pits without
affecting clathrin-independent endocytic pathway, signiﬁcantly
reduces CHIKV infection. Together with observations by Sourisseau
et al. (2007), who used RNA interference strategies, these results
indicate that the clathrin-dependent endocytic pathway mediates
CHIKV entry into human cells. In addition, using lysomotropic agents
(chloroquine, monensin, ammonium chloride and Baﬁlomycine A1)
(M. Solignat, submitted for publication) we found that preventing
endosome acidiﬁcation prior to virus exposure dramatically reduced
CHIKV infection. Our results conﬁrm and extend the data previously
obtained by Sourisseau et al. (2007), who reported that treatment of
HeLa cells with Baﬁlomycin-A1 or chloroquine, inhibited CHIKV
replication cycle. Altogether these data indicate that CHIKV requires
low endosomal pH to productively infected human cells. We ﬁnally
questioned the nature of endocytic vesicle required for CHIKV
transport through the host cell cytoplasm. Indeed, enveloped viruses
that use endocytosis as a route of entry into host cells have different
requirement for both early and late endosomes for entry and
subsequent infection (Sieczkarski and Whittaker, 2003). The trans-Fig. 5. Schematic representation of the capsid protein with the main interaction domains. Ad
98 to 112) is indicated. The N-terminal domain α-helix is indicated and the corresponding am
the RNA-binding domain (Perera et al., 2001) and E2-binding domain (Hahn et al., 1988) a
involved in the serine protease activity are indicated.port, sorting and maintenance of endosomal vesicles along the
endocytic pathway are highly regulated by the Rab-family of GTPases.
Rab5 associates to early endosomal vesicles, the function of which is
mainly to recycle receptors, and is required for the transport of early
endosomes along the microtubules. Rab7 is a marker for late
endosomes, the main function of which is to deliver the ligand to
lysosomes (Schmid et al., 1988) and its activity regulates sorting of
cargo from early endosomes toward the late endosome/lysosome
pathway. To gain insight into the route of endosomal delivery of
CHIKV to human cells, HEK-293T cells expressing either wild type or
dominant negative Rab5 or Rab7 proteins were challenged with
CHIKV. For example, this strategy was used to demonstrate that early
and late endosomes are required for VEEV entry into mosquito cells
(Colpitts et al., 2007). Confocal microscopy analysis revealed that
disrupting Rab5 function by expression of a dominant negative form
of this proteins inhibited CHIKV antigens expression. In contrast, no
signiﬁcant modiﬁcation in the level of CHIKV expressing cells was
evidenced when cells overexpressed a dominant negative form of
Rab7. Accordingly, entry of CHIKV in permissive human cells requires
the integrity of the early endosome compartment while disruption of
the late endosomal compartment has apparently only a very
moderate impact on CHIKV infection.
Intracellular replication of CHIKV
Currently, there is no report in the literature describing experi-
ments performed with CHIKV to explore this virus replicative cycle at
steps taking place after CHIKV has been routed to the endosomes.
Before experimental demonstration became available, general infor-
mation regarding these steps of CHIKV replicative cycle can be
deduced from data obtained with other Alphaviruses and strength-
ened by sequences comparison indicating that amino acid sequences
expected to play a major functional role for an Alphavirus model are
found in the corresponding CHIKV protein.
In Alphaviruses the fusion is mainly a function of E1. Inside the
endosomes, it is generally admitted that the conformational reorga-
nization of the E1–E2 envelope heterodimer, favoured by low pH,
leads to an unstable state of E1 in which its previously buried fusion
peptide is transiently directed toward the target membrane. The
fusion peptide is located at the tip of the E1 molecule in domain II,
close to amino acid 226. Such mechanisms may be conserved for
CHIKV according to sequence conservation and similarities evidenced
within the ribbon representation of the E1 molecule structure of
CHIKV (Schuffenecker et al., 2006). Once delivered to the host cell
cytoplasm, Alphaviruses capsid protein is able to bind large ribosomal
subunit, and this binding reaction could possibly be active in
disassembling nucleocapsids (Singh and Helenius, 1992). A binding
element located at the C-ter end of the capsid sequence of SINV
(Wengler and Wurkner, 1992) is conserved as a PGRRERMCMKIEND
motif in CHIKV capsid protein (position 98 to 112 in the S27 strain)apted after Perera et al. (2001). The conserved ribosome-binding sequence (amino acids
ino acid sequence is shown for CHIKV and related viruses. The approximate location of
re indicated. The amino acid residues (H139, D-145, D161, S213), that are likely to be
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pathway. It takes place in the host cell cytoplasm and is associated
with membranous structures of the cytoplasm that copurify with the
mitochondrial fraction of infected cells (Gomatos et al., 1980). The
composition of replication complex changes along infection (Shirako
and Strauss, 1994). Early after infection, minus-strand RNAs (only
detected at early stage of infection) and plus-strand (synthesized at a
constant rate throughout the remainder of infection cycle) are both
transcribed under control of non-structural proteins (nsPs). Non-
structural proteins of CHIKV (e.g., S27 strain) are encoded by an open
reading frame (ORF) of 7424 nucleotide initiated by an ATG at
position 77/79 from the 5′ cap site of the 49S non-structural RNA and
terminated by a TAG at position 7499/7501. This ORF encodes a
polyprotein precursor of 2474 amino acids termed nsP123 that
produces the different nsP, once proteolytically cleaved. According to
data available for related Alphaviruses, after synthesis and maturation,
the nsP123 precursor is expected to complex with the free nsP4
protein and host cell proteins to act as a minus-RNA strand replicase
catalyzing the synthesis of the negative-strand RNA (Barton, Sawicki,
and Sawicki, 1991). In CHIKV (e.g., S27 strain) the nsP4 protein is a
611 amino acids long protein that shows 91% identity with ONNV-
nsP4. The presence of a RNA-dependent polymerase motif GDD,
common to many RNA-dependent polymerases, near the C-ter at
position 464–467 in nsP4 supports a similar function for CHIKV
encoded nsP4. Together with nsP4, nsP1 is expected to catalyze the
initiation (or continuation) of the negative-strand RNA synthesis. This
protein is also involved in methylation and caping of the positive RNA
(Mi et al., 1989). Indeed, CHIKV nsP1, a 535 amino acids long protein
contains a consensus sequence (Q31-VTPNDHANARAFSHL-A47) at
the N-ter region which is characteristic of Alphaviruses. The nsP3
protein also participates in the transcription of negative strands early
in infection (Wang, Sawicki, and Sawicki, 1994). The nsP3 RNA
replicase of CHIKV (e.g., S27 strain), is 530 amino acids long. It has two
distinct domains, a N-ter which is conserved among Alphavirus (51%
amino acid sequence identity at minimum), and a C-ter which varies
signiﬁcantly both in sequence and length among Alphaviruses (i.e.,
134 amino acid in MIDV up to 246 amino acid for ONNV). Sequences
comparison highlighted that the N-ter of nsP3 is related to the family
of H2A histone/macro domain that are widely found in bacteria,
plants and animals and conserved during evolution (Pehrson, 1998).
A recent comparison of CHIKV and VEEV macro domains demon-
strated a 57% sequence identity (Malet et al., 2009). Structure of
CHIKV nsP3 deﬁned by the same group with a 1.65 Å resolution,
revealed that macro domain in nsP3 displays an ADP-ribose binding
capacity. This RNA-binding property is enhanced by the presence of
positively charged patches of amino acid at the surface of the protein.
In addition this domain in CHIKV shares di-phosphoribose 1″-
phosphate phosphatase activity with other macro domain-containing
proteins. This activity is barely detected for SFV (Egloff et al., 2006).Fig. 6. Schematic representation of the non-structural protein nsP2, showing the location of
used for numbering is CHIKV sequence (Khan et al., 2002). The proteinase cleavage sites in th
of CHIKV is from Khan et al. (2002); the other sequences are from Strauss and Strauss (199Despite the role of CHIKV macro domain remains elusive, the RNA-
binding capacity of nsP3 could assist the recruitment of RNA by non-
structural proteins. The non-conserved C-ter domain of nsP3 supports
important deletions without apparent changes in the replication
potential of the mutant virus, as demonstrated for VEEV (Davis et al.,
1989). All Alphavirus nsP3 C-ter domains are rich in acidic residues as
well as in serine and threonine. Although nsP3 of all Alphaviruses are
globally negatively charged, it is worth noting that CHIKV and ONNV
(−24 and −25 global charge, respectively), contain much more
negatively charged amino acids than other members of the same
group (−12 and −10 global charge for RRV and SFV, respectively).
Using the SINV model, it has been found that nsP3 is heavily
phosphorylated on serine or threonine residues, likely by several
cellular kinase (Li et al., 1990). Phosphorylation of SINV nsP3 is likely
required for efﬁcient RNA synthesis and viral pathogenicity (Vihinen
et al., 2001). Although there are several putative sites for phosphor-
ylation within CHIKV nsP3 (S-320 and S-335 amino acids) which are
also conserved in ONNV, suggesting that these residues probably
control CHIKV nsP3 functions similarly to other alphaviral nsP3
proteins, there is so far no equivalent data available for CHIKV.
During replication, when the concentration of nsP123 in the cell is
high enough to support an efﬁcient bimolecular reaction, the
precursor is further processed into mature proteins. In CHIKV, three
cleavage sites similar to those present in other Alphaviruses are found
in nsP123. To the exception of the nsP2/nsP3 cleavage site in WEEV
and EEEV sequences, Alphaviruses nsP precursor cleavage sites are
characterized as follows: the C-ter (n−1) residue is usually an amino
acid with a small side chain (i.e., alanine, cysteine, glycine), the n−2
residue is invariably a glycine that is required for nsP2 catalytic
activity and the n−3 is most frequently an alanine (Fig. 6). n−2
glycine and n−3 alanine residues are conserved in CHIKV sequence.
The fully cleaved precursor complexed together with host cell
proteins act as a plus-strand RNA replicase to amplify the full-length
subgenomic (26S) positive-strand mRNA using the negative-strand
RNA as a template (Shirako and Strauss, 1994). Both steps are
regulated by helicase and proteinase functions of nsP2 protein whose
proteolytic cleavage plays a pivotal role in the viral replication
process. The nsP2 of CHIKV (e.g., S27 strain) is a 798 amino acids long
positively charged protein (net positive charge of +21). The degree of
amino acid identity between nsP2 of CHIKV and other Alphaviruses
ranges from 56% forWEEV up to 98% for ONNV. This protein contains a
proteinase motif (CWA) at position 478–480 of nsP2 (Fig. 6). For SINV,
the C481 residue is required for protease activity and forms the
catalytic dyad together with W558 (Hardy and Strauss, 1989; Strauss
and Strauss, 1994). In addition, the nucleoside triphosphate-binding
motives (GVPGSGKS and DEAF) characteristic for Alphaviruses
replicases are located in the N-ter of CHIKV nsP2 at position 186–
193 and at position 252–255, respectively. Accordingly, although
unproven experimentally, CHIKV nsP2 should retain both a proteasethe consensus sequences for the helicase and the proteinase, respectively. The sequence
e nsPs (nsP1/nsP2, nsP2/nsP3, and nsP3/nsP4), are shown in the lower panel (sequence
4).
191M. Solignat et al. / Virology 393 (2009) 183–197activity that catalyzes the cleavage of the precursor polypeptide to
yield the mature nsP proteins and a RNA helicase function.
The subgenomic positive-strand mRNA of Alphaviruses, referred to
as 26S RNA, serves as themRNA for the synthesis of the viral structural
proteins. For CHIKV, the ORF encoding the structural proteins is
composed of 3735 nucleotides with an initiation at position 7567 and
termination at position 11,299. This ORF encodes a polyprotein of
1244 residues from which the individual structural proteins are
formed. This precursor is processed co-translationally and post-
translationally into structural proteins C, PE2 and E1, and a small
peptide termed 6K (that may act as a signal sequence for the
translocation of E1). The capsid protein of CHIKV is 261 amino acids
long. This protein of apparent molecular weight of 30 kDa, consists of
an N-ter region of unknown function and poorly conserved among
Alphaviruses except in a short region (43-KAGQLAQLISAVNKLTMR-
60) predicted to play a role in the assembly of nucleocapsid cores, and
of a C-ter region showing a conserved autoprotease domain (Fig. 5).
For other Alphaviruses this later domain retains a serine protease
activity acting in cis to release itself from the nascent polypeptide
chain (Strauss and Strauss, 1990). The 3-D structure of the SINV capsid
protein has been solved and it was found that the C-ter region folds
homologous to that of chymotrypsin (Choi et al., 1991). It has been
reported that residue S215 is the catalytic serine of the proteinase and
that other important amino acids are H141, D147 and D161 (Hahn
and Strauss, 1990). By comparing the SINV capsid sequence (264
amino acids) to the slightly shorter CHIKV capsid sequence (261
amino acids) (Khan et al., 2002), it can be identiﬁed as H139, D145,
D161 and S213, suggesting that these conserved amino acid may be
involved in CHIKV capsid autoprotease activity. Once the nucleocapsid
protein is released from the nascent polypeptide chain, an N-terminal
signal sequence leads to the insertion of glycoprotein PE2 into the
endoplasmic reticulum. The signal sequence has a carbohydrate
attachment site at an asparagine residue between residues 11 and 14
in all Alphaviruses examined (residue 12 in CHIKV S27 strain; PE2 start
by: 1-SLAIPVMCLLAN-12), and it has been postulated that the
addition of carbohydrate to this site is responsible for the retention
of the signal sequence in PE2 (Garoff et al., 1990). With respect to
observations made using Alphaviruses other than CHIKV (Strauss and
Strauss, 1994), the cleavage between PE2 and 6K, catalyzed by
signalase in the lumen of the ER, gives rise in CHIKV to a 6K protein of
61 amino acids long.
CHIKV assembly, budding, and maturation
Almost nothing is known regarding these steps of the virus
replication cycle for CHIKV, and very few information can be
extrapolated from sequence comparison between CHIKV envelope
proteins and the corresponding proteins of other Alphaviruses. The E1
protein of CHIKV contains 435 amino acids. This protein of apparent
molecular weight 44 kDa, has one possible glycosylation site (N-X-S/
T, were X is any amino acid except proline), at position 141–143 (N-
141, I-142, T-143, respectively). The E1 amino acid of CHIKV shows
88% identity to ONNV-E1. Interestingly, residue C-433 in the E1 of SFV
which has been considered as a target for palmitoylation is conserved
in CHIKV. Information gained from SFV indicates that after being
transported to the trans Golgi, the PE2–E1 heterodimer moves to the
cell surface. During this step, PE2 is cleaved by a cellular furin or furin-
like proteinase to form E2 and E3 (de Curtis and Simons, 1988). The
PE2 precursor has been clearly identiﬁed in the case of CHIKV as being
a 65 kDa protein (Simizu et al., 1984). Quite recently, it has been
reported that the PE2 of CHIKV can be cleaved by furin and the PC5A
convertase. Inhibition of PE2 processing can be achieved by the furin
inhibitor decanoyl-RVKR-chloromethyl ketone (Ozden et al., 2008).
By SDS-PAGE analysis, it was shown that the E2 protein migrates
faster than the E1 protein. Moreover, tunicamycine treatment of
producer cells resulted in a higher electrophoretic mobility observedfor PE2 and E1, supporting that both proteins are glycosylated
(Konishi and Hotta, 1980; Simizu et al., 1984). The E2 protein contains
423 amino acids and shows 82% amino acid identity with ONNV E2
protein. This protein of apparent molecular weight 43 kDa has two
possible glycosylation sites, at positions 263 and 345, Three putative
palmitoylated cysteine residues are strongly conserved at the C-
terminus of E2 for CHIKV and other Alphaviruses (Ivanova and
Schlesinger, 1993; Schmidt et al., 1988) suggesting that these
modiﬁcations are critical for protein function. Fatty acylation of the
corresponding cysteine residues is expected to be responsible for
translocation of E2 from the lumina to the cytoplasmic side of the
endoplasmic reticulum, as described for SINV (Ivanova and Schle-
singer, 1993). The E3 protein of CHIKV consists of 64 amino acids and
shows an apparent molecular weight of 11 kDa. E3 of CHIKV, is not
associated with virions but is released from infected cells (Simizu et
al., 1984). In addition to the four conserved cysteine residues present
in E3 proteins of Alphaviruses, E3 from CHIKV contains an additional
cysteine/proline rich PPCIXCC sequence also present in E3 proteins
from 50% of Alphaviruses, including that from ONNV (Parrott et al.,
2009). The function of CHIKV E3 protein has not been studied so far,
yet it could share disulﬁde isomerase activity recently described for
SINV E3 protein that could be involved in proper folding and disulﬁde
bound formation in viral envelope glycoprotein spike formation
(Parrott et al., 2009).
Alphavirus virion assembly starts with nucleocapsid assembly in
the cytoplasm. The nucleocapsid of Alphaviruses is characterized by an
icosahedral symmetry (with T=4 symmetry) and consists of the viral
RNA encapsidated with 240 copies of the C protein. Nucleocapsids of
related viruses are known to contain a putative coiled-coil α-helix
important for core assembly that is conserved in CHIKV C protein
(Perera et al., 2001) (Fig. 5). Deletion analysis of SINV capsid showed
that the N-ter region extending from amino acid 76 to 107 is also
essential for full-length progeny RNA-binding and packaging (Gei-
genmuller-Gnirke, Nitschko, and Schlesinger, 1993). From the same
model, it has been shown that the RNA region between residues 746
and 1226 is speciﬁcally bound by the nucleocapsid (Strauss and
Strauss, 1994; Weiss et al., 1989). Thus, the genomic RNA-binding
region overlaps the region required for binding to the large ribosomal
subunit. The capsid protein probably forms RNA-bound dimers
initiated by interactions through residues 81–261 and next the
coiled-coil interactions mediated through the α-helix stabilize the
nucleic-acid bound dimers. The lateral interactions with other capsid
proteins determine the structure of the icosahedral shell. A total of
120 copies of these dimers further oligomerize to form the
nucleocapsid of CHIKV (Perera et al., 2001). Nucleocapsid complexes
assembled in the cell cytoplasm are thought to diffuse freely to the
plasma membrane.
Alphaviruses bud through the cell membrane. Virions acquire a
lipid bilayer envelope containing the virus-encoded E1 and E2
glycoproteins. The mature envelope glycoprotein spikes are com-
posed of trimers of E1–E2 (Ekstrom, Liljestrom, and Garoff, 1994). The
envelope of Alphaviruses contains 240 copies of two virus-encoded
glycoproteins, E1 and E2, organized into 80 trimers of E1–E2
heterotrimers (Fuller, 1987). During budding, the nucleocapsid
appears to undergo a maturation event and requires binding to E2
for appropriate targeting to the cell membrane (Suomalainen,
Liljestrom, and Garoff, 1992). Using RRV-SINV chimeras it was
shown that these capsid-E2 interactions involved residues within
the 33 amino acids of E2 cytoplasmic domain (RRV: 390-TARRKCLT-
PYALTPGAVVPLTLGLLCCAPRANA-422) (Lopez et al., 1994); a similar
sequence: RRRCITPYELTPGATVPFLLSLICCIRTAKA is found in CHIKV
(Fig. 7). As previously discussed, WEEV arose by recombination
between EEEV and the SINV (Hahn et al., 1988; Weaver et al., 1997).
The recombinant virus contains the glycoprotein of the SINV-like
parent but the nucleocapsid protein of the EEEV parent. Changes were
evidenced in both capsid and E2 of WEEV likely as a consequence of a
Fig. 7. Schematic representation of the E2 envelope glycoprotein. Adapted after Zhao et al. (1994). The amino acid sequences of the E2 cytoplasmic domain from different viruses are
shown. The sequence of CHIKV is from Khan et al. (2002) (NCBI, accession no. AF369024). The Cysteine residues (C) are believed to be palmitoylated and this could serve to anchor
the E2-tail at the surface of the inner membrane. The NetPhos sequence analysis (www.Cbs.dtu.dk/services/NetPhos/) predicts that threonines (T) are likely to be phosphorylated
(℗) whereas the tyrosine (Y) is probably not. A stretch of highly conserved residues TP, is characteristic of an ERK2 phosphorylation site.
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parents to one another. In the C-ter cytoplasmic domain of E2, there
are 8 amino acid differences betweenWEEV and SINV among which 4
are changed to the EEEV sequence.
The nucleocapsid, E1 and E2 glycoproteins are phosphorylated (Liu
et al., 1996; Waite et al., 1974). At least some of these phosphoryla-
tions might play a role in the assembly and/or post-assembly steps
since the use of protein kinase or phosphatase inhibitors interfere
with viral maturation (Liu and Brown, 1993). In the presence of
calmodulin/Ca2+ dependent protein kinase inhibitor (i.e., W7
inhibitor), there is an aberrant assembling of nucleocapsid units
which form high ordered complexes into the cell cytoplasm but fail toFig. 8.HEK-293T cells (A and B) chronically infected with CHIKVwere ﬁxedwith glutaraldehy
evidence of budding and the presence of an electron-dense mature particle (white arrow).
material bordered with a membrane bilayer (black arrow). The bar corresponds to 100 nm
membrane (black arrow). The bar corresponds to 100 nm. Similar experiments were perform
presence of several electron-dense particles budding at the cell surface. The bar correspond
The bar corresponds to 90 nm. Two different types of particles can be observed, viral particle
about 76 nm showing only a small electron-dense material in the middle very similar to the
one example of the presence of CHIKV particles within cellular vacuoles. Particles found wiparticipate to virus particles formation at the cell membrane (Liu and
Brown, 1993). Finally, phosphorylation of T398 and Y400 residues is
considered important for cellular subcompartment translocation and
assembly of virions (Liu et al., 1996). To date, the ﬁnal stages of the
CHIKV replication cycle have not been investigated and most
assumptions from other Alphavirus models remain to be tested. We
have observed CHIKV budding in electron microscopy experiments.
As shown in Fig. 8, HEK-293T human cells (Figs. 8A and B) chronically
infected with CHIKV show evidence for budding of small viral
particles at the surface of infected cells. It is worth noting that only
a low percentage of particles show high electron density characteristic
for maturation. A similar investigation performed using thede 48 h after infection and processed for thin-layer electronmicroscopy. Panel A, shows
Most of the particles (size ranging from 45 to 80 nm) are characterized by low density
. Panel B illustrates the budding of larges particles with low density material at the cell
ed using BHK-21 cells (C, D, and E) chronically infected with CHIKV. Panel C shows the
s to 100 nm. Panel D, illustrated the massive production of particles from BHK-21 cells.
s of about 65 nm with an electron-dense capsid of 32 nm (white arrow) and particles of
most frequent particles observed in CHIKV-infected HEK-293 T cells. Panel E illustrates
thin the endosomes appear to be electron-dense. The bar corresponds to 300 nm.
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budding of viral particles with electron-dense capsids and the
production of higher proportions of mature particles. The mature
CHIKV particles were also observed within endosomal vesicles (Fig.
8E), probably during the propagation of the virus to neighbouring
cells. It has been suggested that the envelope of the mature Alpha-
virus particle must be derived from a segment of the plasma
membrane from which all host cell proteins are excluded (Garoff
and Simons, 1974; Strauss, 1978). This contrast with other enveloped
RNA viruses which acquire envelope by budding at the cell surface,
such as HIV for which the presence of cellular compound associated
to virions has been well-documented. Cellular materials such as CD3,
CD4, CD5, CD11a, CD18, CD25, CD30, CD43, CD54, CD63, CD71, HLA
class I, and HLA-DR have been detected as integral components of
cell-free HIV-1 virions or contaminants that are difﬁcult to remove
(Arthur et al., 1992; Benkirane et al., 1994; Briant et al., 1996;
Hildreth and Orentas, 1989). It is therefore likely that further
investigations using highly sensitive methods, would demonstrate
the presence of cellular compounds associated to CHIK virions.
Similarly, despite it was concluded from preliminary results, that no
kinase activity was incorporated into Alphaviruses (Waite et al., 1974)
low kinase activity has been found speciﬁcally associated with viral
preparations of SINV and SFV ultrapuriﬁed by co-sedimentation in
sucrose (Tan and Sokol, 1974). In addition, protein phosphatase
activity is also incorporated into Alphaviruses particles (Tan and
Sokol, 1974). In other enveloped RNA viruses, such as retrovirus HIV-
1 and HTLV-1, we and others have demonstrated that cellular kinases,
active during budding or packaged into the virus particle, play
essential role in the replicative cycle of the virus (Cartier et al., 2003;
Hemonnot et al., 2004; Hemonnot et al., 2006). The presence
of cellular protein kinase in CHIKV particles would merit to be
addressed.
According to this sum of sequence-derived information, a
synthetic view of the possible CHIKV replicative cycle can be drawn
as presented in Fig. 9.Fig. 9. Summary of the CHIKV replication cycle. The different steps ofProspects for treatment of CHIKV infection
Experiments to improve our understanding of CHIKV genomic
organization, cell tropism/cell surface receptor(s) binding, and the
different steps of the virus replication cycle are ongoing. This
understanding is an important prerequisite for evaluating models to
predict future CHIKV evolution and then develop novel therapies and
vaccination strategies to reduce disease incidence. This review
summarizes the most recent knowledge about human host cells–
CHIKV interactions. Based on the increasing sum of information
recently gained on the CHIKV replication cycle, therapeutic strategies
aiming at inhibiting replication and controlling propagation in
infected humans should be soon evaluated in humans. Some of
these promising strategies are discussed below.
Togaviruses are known to stimulate interferonproduction in the host
cell and interferon impacts viral replication in return. It has been
reported a long time ago, that priming of target cells with low doses of
interferon before infection with CHIKV impacted on the virus
replication cycle (Paucker and Boxaca, 1967) while treatment of
infected cells with the interferon inhibiting agent actinomycin D,
enhances CHIKV replication (Gifford and Heller, 1963; Heller, 1963).
Very recent observations performed in a mouse model knocked out for
IFNα/β receptors genes, demonstrated that the severity of CHIKV
infection is critically dependent on the functionality of type-I IFN
signalling (Couderc et al., 2008).Moreover, differences inTNF-signalling
capacities were proposed as the basis for discrepancies observed for
CHIKV sensitivity between adult and neonates mice. Despite the
synergistic inhibition of in vitroCHIKV replicationhas beendocumented
for α-interferon and ribavirin combination, Briolant et al. (2004)
interferon treatment has not been evaluated in vivo against CHIKV, to
the best of our knowledge. However, whatever the in vivo effect of
interferon against CHIKV in humans, it would be difﬁcult to use for
treatmentof CHIKV-infectedpatients in the case of anepidemic episode.
Additional therapeutic strategies may consist in boosting immune
responses against speciﬁc CHIKV sequences. Indeed vaccinationthe CHIKV replication cycle are described in detail in this review.
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The most important mechanisms by which the immune system
protects an animal from viral diseases are the neutralization of virus
infectivity by the humoral response (neutralizing antibodies), and
virus-infected cell lysis by the cellular response (cytoxic T cells).
Although very few data has been accumulated regarding anti-CHIKV
antibody response, special attention has been devoted, on antibodies
able to neutralize Alphaviruses. In response to SINV infection, the
neutralizing antibody response is more frequently directed against
the glycoprotein E2 rather than against E1 (Strauss et al., 1991).
Following infection with RRV, neutralizing epitopes in E2 have also
been described (Vrati et al., 1988) supporting that neutralizing
antibodies directed against E2 may apply to many Alphaviruses. It is
not our purpose to review the development of vaccine against CHIKV
in this review. However, it is worth noting that studies performed in
order to design a protective vaccine against CHIKV provide indications
that neutralizing epitopes are shared between different strains of
CHIKV (Eckels, Harrison, and Hetrick, 1970; Edelman et al., 2000;
Harrison et al., 1967, 1971; Kitaoka, 1967; Levitt et al., 1986; White et
al., 1972). The capsid protein of CHIKV has been shown to represent a
dominant target for CD8 lymphocytes in mouse (Linn et al., 1998). H-
2Kd restricted Alphavirus-speciﬁc CTL that recognize the QYSGGRFTI
sequence of CHIKV capsid protein (a region believed to be involved in
binding to the surface glycoprotein E2), can clear a cytopathic CHIKV
infection from a persistent and productively infected macrophage
culture (Linn et al., 1998). If the target of anti-CHIKV CTL activity was
located to a small region of the capsid protein in humans, this might
restrict the ability of individuals to generate CTL only to certain
persons with the appropriated HLA genotype. Pertaining to this point,
it has been reported that patients who rapidly recovered from RRV
disease have developed a strong anti-RRV CD8+ CTL response (Fraser
et al., 1983).
Since enveloped viruses utilize membrane-bound proteins to
mediate attachment and entry into speciﬁc target host cells, peptides
that mimic portions of their envelope glycoproteins can likely inhibit
infectivity. This has been previously demonstrated for several virus
including HIV, DENV, andWNV (Hrobowski et al., 2005; Qureshi et al.,
1990). Pertaining to this point, it is important to emphasize that cell
surface receptors not only permit the enveloped virus to attach cells
but can also serve to deliver aberrant signals to the target cell as
demonstrated for several enveloped viruses including HIV and WNV
(Briant et al., 1998; Glass et al., 2006; Lee et al., 2006; Roggero et al.,
2001). Considering the requirement for envelope protein rearrange-
ment during virus entry and the role played by disulﬁde bonds during
this process, membrane impermeant sulfhydryl reagents capable of
blocking thiol-disulﬁde bonds, were analysed for antiviral properties
and partial inhibition of SFV and SINV was observed for the 5-5′-
dithio-bis (2 nitrobenzoic acid), DTNB thiol-blocker (Glomb-Rein-
mund and Kielian, 1998).
We have previously discussed herein the fact that entry of CHIKV
into the cell cytoplasm likely occurs by endocytosis in clathrin-coated
vesicles followed by transfer to endosomes where the low pH leads to
a conformational reorganization of the E1–E2 heterodimer such that
the fusion domain in E1 is exposed, and the virus envelope fuses with
the endosomal membrane. In the past, chloroquine (a quinoline that
displays anti-inﬂammatory properties and is mainly known as the
antimalarial Nivaquine) has been assayed for treatment of chronic
CHIKV arthritis (Brighton, 1984). Due to its main effect—i.e., raising
endosomal pH—the drug also has an exceptionally broad spectrum of
antimicrobial activity allowing inhibition of viruses from different
families which require a pH-dependent step for entry. Another
possibility is that glycosylation inhibition (inhibition of biosynthesis
of sialic acid moieties that are present on viral envelope glycopro-
teins) might represent an alternative mechanism for the antiviral
effect of chloroquine (Savarino et al., 2006). The anti-CHIKV effect of
chloroquine was conﬁrmed by in vitro experiments performed bymembers of the Sentinelles France's national disease surveillance
network on chikungunya (de Lamballerie and Canard, 2006).
However, the double blind placebo-controlled clinical trial performed
on the Reunion Island that included 27 CHIKV-infected patients who
received Nivaquine at 10 mg/kg during three days followed by
treatment at 5 mg/kg was not convincing enough to justify further
investigations of the potential use of this molecule in managing acute
CHIKV infection (De Lamballerie et al., 2008). A thorough under-
standing of the routes used by this virus to infect its target cells may
help to design new antiviral strategies that break the human/vector
infection cycle. One should expect that in vitro, in silico, ex-vivo, and
in vivo screening of drugs directed against the different CHIKV
molecules should rapidly provide candidates for treatment of
patients. Systematic screening of FDA approved molecules to be
adapted for new prescription either isolated or as multicomponent
therapies (Borisy et al., 2003), may represent an interesting strategy.
For example, nsP2 that belongs to the highly conserved superfamily of
proteins containing nucleoside triphosphate-binding domains (Gor-
balenya et al., 1989) may represent an attractive target. Vidalain et al.
(2007) have recently reported interaction of nsP2 with cellular
transcription factors using a 2-hybrid screening strategy. Based on
these results, a bank of 35,000 chemical compounds is currently under
screening to select inhibitors of CHIKV. Similarly, the recent
characterization and structure resolution of CHIKV nsP3 macro
domain (Malet et al., 2009) combined to the high degree of
conservation of these motives in bacteria (Pehrson and Fuji, 1998)
opens the way to the evaluation of the antiviral potential of available
anti-bacterial compounds and subsequently to a rational structure-
based optimization. Finally, several possibilities also exist that may
consist in inhibiting CHIKV assembling and/or budding. Interestingly,
peptides that mimic the E2 tail of Alphaviruses, inhibit virus
production probably by preventing C-E2 interactions (Collier et al.,
1992). More recently it was shown that decanoyl-RVKR-chloromethyl
ketone, a furin inhibitor, blocked the cleavage of PE2 into E2 and E3
and thereby inhibited CHIKV spreading in myoblast cell cultures
(Ozden et al., 2008).One can expect that among these research some
will open new avenues for anti-CHIKV therapy.
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